NewAmsterdam Pharma Co N.V (NAMS) Operating Margin: 2023-2025
Historic Operating Margin for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Sep 2025 value amounting to -15,845.69%.
- NewAmsterdam Pharma Co N.V's Operating Margin fell 1575980.00% to -15,845.69% in Q3 2025 from the same period last year, while for Sep 2025 it was -575.81%, marking a year-over-year decrease of 2769.00%. This contributed to the annual value of -386.91% for FY2024, which is 91165.00% up from last year.
- According to the latest figures from Q3 2025, NewAmsterdam Pharma Co N.V's Operating Margin is -15,845.69%, which was down 8,413.14% from -186.13% recorded in Q2 2025.
- In the past 5 years, NewAmsterdam Pharma Co N.V's Operating Margin registered a high of -85.89% during Q3 2024, and its lowest value of -15,845.69% during Q3 2025.
- In the last 3 years, NewAmsterdam Pharma Co N.V's Operating Margin had a median value of -2,306.93% in 2024 and averaged -3,274.48%.
- As far as peak fluctuations go, NewAmsterdam Pharma Co N.V's Operating Margin surged by 602,193bps in 2024, and later plummeted by 1,575,980bps in 2025.
- NewAmsterdam Pharma Co N.V's Operating Margin (Quarterly) stood at -6,360.40% in 2023, then spiked by 602,193bps to -338.47% in 2024, then slumped by 1,575,980bps to -15,845.69% in 2025.
- Its last three reported values are -15,845.69% in Q3 2025, -186.13% for Q2 2025, and -2,314.47% during Q1 2025.